These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10191115)

  • 1. Expression studies of CLN3 protein (battenin) in fusion with the green fluorescent protein in mammalian cells in vitro.
    Golabek AA; Kaczmarski W; Kida E; Kaczmarski A; Michalewski MP; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):277-82. PubMed ID: 10191115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of intracellular distribution and trafficking of the CLN3 protein in fusion with the green fluorescent protein in vitro.
    Kida E; Kaczmarski W; Golabek AA; Kaczmarski A; Michalewski M; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):265-71. PubMed ID: 10191113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttranslational modification of CLN3 protein and its possible functional implication.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Mol Genet Metab; 1999 Apr; 66(4):272-6. PubMed ID: 10191114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for phosphorylation of CLN3 protein associated with Batten disease.
    Michalewski MP; Kaczmarski W; Golabek AA; Kida E; Kaczmarski A; Wisniewski KE
    Biochem Biophys Res Commun; 1998 Dec; 253(2):458-62. PubMed ID: 9878558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of membrane association of CLN3 protein.
    Kaczmarski W; Wisniewski KE; Golabek A; Kaczmarski A; Kida E; Michalewski M
    Mol Genet Metab; 1999 Apr; 66(4):261-4. PubMed ID: 10191112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression studies of CLN3 protein.
    Kaczmarski W; Kida E; Lach A; Rubenstein R; Zhong N; Wisniewski KE
    Neuropediatrics; 1997 Feb; 28(1):33-6. PubMed ID: 9151318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does lens intrinsic membrane protein MP19 contain a membrane-targeting signal?
    Chen T; Li X; Yang Y; Erdene AG; Church RL
    Mol Vis; 2003 Dec; 9():735-46. PubMed ID: 14735063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLN3 defines a novel antiapoptotic pathway operative in neurodegeneration and mediated by ceramide.
    Puranam KL; Guo WX; Qian WH; Nikbakht K; Boustany RM
    Mol Genet Metab; 1999 Apr; 66(4):294-308. PubMed ID: 10191118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal prenylation of the CLN3 membrane glycoprotein is required for efficient endosomal sorting to lysosomes.
    Storch S; Pohl S; Quitsch A; Falley K; Braulke T
    Traffic; 2007 Apr; 8(4):431-44. PubMed ID: 17286803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
    Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
    Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dileucine motif and a cluster of acidic amino acids in the second cytoplasmic domain of the batten disease-related CLN3 protein are required for efficient lysosomal targeting.
    Storch S; Pohl S; Braulke T
    J Biol Chem; 2004 Dec; 279(51):53625-34. PubMed ID: 15469932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse transporter protein, a membrane protein that regulates cellular multidrug resistance, is localized to lysosomes.
    Cabrita MA; Hobman TC; Hogue DL; King KM; Cass CE
    Cancer Res; 1999 Oct; 59(19):4890-7. PubMed ID: 10519401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
    Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
    Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.
    Karan G; Yang Z; Zhang K
    Mol Vis; 2004 Mar; 10():248-53. PubMed ID: 15073583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein.
    Mole SE; Michaux G; Codlin S; Wheeler RB; Sharp JD; Cutler DF
    Exp Cell Res; 2004 Aug; 298(2):399-406. PubMed ID: 15265688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.